| 1. |
Spaide RF, Yannuzzi LA, Slakter JS, et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy[J]. Retina, 1995, 15(2): 100-110. DOI: 10.1097/00006982-199515020-00003. DOI: 10.1097/00006982-199515020-00003.
|
| 2. |
Han LH, Yuan LF, Liang X, et al. Combined therapy versus anti-vascular endothelial growth factor monotherapy for polypoidal choroidal vasculopathy: a meta-analysis[J]. Int Ophthalmol, 2017, 10(8): 1280-1289. DOI: 10.18240/ijo.2017.08.16.
|
| 3. |
Lin HC, Yang CH, Yang CM, et al. Visual outcomes of vitrectomy for polypoidal choroidalvasculopathy-related breakthrough vitreoushaemorrhage[J]. Eye, 2014, 28(7): 797-806. DOI: 10.1038/eye.2014.124.
|
| 4. |
李莉, 梁永波, 陳玲, 等. 核固紅染液不同配制方法對含鐵血黃素染色的影響[J]. 臨床與實驗病理學雜志, 2020, 36(7): 861-863. DOI: 10.13315/j.cnki.cjcep.2020.07.030.Li L, Liang YB, Chen L, et al. Effect of different preparation methods of nuclear solid red dye on hemosiderin staining[J]. J Clin Exp Pathol, 2020, 36(7): 861-863. DOI: 10.13315/j.cnki.cjcep.2020.07.030.
|
| 5. |
Lincoff H, Madjarov B, Lincoff N, et al. Pathogenesis of thevitreous cloud emanating from subretinal hemorrhage[J]. Arch Ophthalmol, 2003, 121(1): 91-96. DOI: 10.1001/archopht.121.1.91.
|
| 6. |
Jalali S, Parra SL, Majji AB, et al. Ultrasonographic characteristics and treatment outcomes of surgery for vitreous hemorrhage in idiopathic polypoidal choroidal vasculopathy[J]. Am J Ophthalmol, 2006, 142(4): 608-619. DOI: 10.1016/j.ajo.2006.05.055.
|
| 7. |
張霜, 張杰, 徐鑫彥, 等. 組織型纖溶酶原激活劑、雷珠單抗聯合C3F8治療息肉樣脈絡膜血管病變并發早期黃斑下出血的療效觀察[J]. 中華眼底病雜志, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.Zhang S, Zhang J, Xu XY, et al. The efficacy of intravitreal injection of tissue plasminogen activator, ranibizumab and C3F8 in the treatment of early submacular hemorrhage induce to polypoid choroid vasculopathy[J]. Chin J Ocul Fundus Dis, 2018, 34(5): 448-452. DOI: 10.3760/cma.j.issn.1005-1015.2018.05.007.
|
| 8. |
Zhao XY, Luo MY, Meng LH, et al. The incidence, characteristics, . management, progrosis and classifceation of breakthrough vite ous hemorhage secondary to polypoidal choroidal vasculopathy[J]. Retina, 2021, 41(8): 1675-1685. DOI: 10.1097/IAE.0000000000003098.
|
| 9. |
周海英, 紀海霞, 楊萱, 等. 玻璃體切除術治療息肉樣脈絡膜血管病變繼發玻璃體積血的療效及影響因素[J]. 眼科, 2022, 31(3): 181-187. DOI: 10.13281/j.cnki.issn.1004-4469.2022.03.004.Zhou HY, Ji HX, Yang X, et al. Efficacy and effective factors of vitrectomy for vitreous hemorrhage secondary to polypoidal choroidal vasculopathy[J]. Ophthalmol CHN, 2022, 31(3): 181-187. DOI: 10.13281/j.cnki.issn.1004-4469.2022.03.004.
|
| 10. |
毛子清, 吳宏禧, 鄒玉凌, 等. 息肉樣脈絡膜血管病變眼內出血的內外路聯合手術療效觀察[J]. 中華眼底病雜志, 2020, 36(7): 504-508. DOI: 10.3760/cma.j.cn511434-20190412-00145.Mao ZQ, Wu HX, Zou YL, et al. Curative effect of internal and external combined surgery for intraocular hemorrhage of polypoidal choroidal vascular disease[J]. Chin J Ocul Fundus Dis, 2020, 36(7): 504-508. DOI: 10.3760/cma.j.cn511434-20190412-00145.
|
| 11. |
徐恩沛, 孫先勇, 高榮玉, 等. 視網膜下抽液聯合玻璃體內注射康柏西普和氣體治療息肉樣脈絡膜血管病變并發漿液性視網膜色素上皮脫離的療效和安全性[J]. 眼科新進展, 2024, 44(3): 208-212. DOI: 10.13389/j.cnki.rao.2024.0041.Xu EP, Sun XY, Gao RY, et al. Efficacy and safety of subretinal fluid extraction combined with intravitreal injection of conbercept and gas in the treatment of polypoidal choroidal vasculopathy complicated with serous retinal pigment epithelium detachment[J]. Rec Adv Ophthalmol, 2024, 44(3): 208-212. DOI: 10.13389/j.cnki.rao.2024.0041.
|
| 12. |
楊秀芬, 趙露, 尤冉, 等. 視網膜切開治療息肉樣脈絡膜血管病變伴出血性視網膜脫離2例[J]. 臨床眼科雜志, 2018, 26(2): 182-183. DOI: 10.3969/j.issn.1006-8422.2018.02.026.Yang XF, Zhao L, You R, et al. Two cases of polypoid choroidal vasculopathy with hemorrhagic retinal detachment treated by retinotomy[J]. J Clin Ophthalmol, 2018, 26(2): 182-183. DOI: 10.3969/j.issn.1006-8422.2018.02.026.
|
